AstraZeneca Argues Standing Before Judge in Drug Price Challenge

AstraZeneca told a federal judge it has constitutional and prudential standing to bring its due process claim in a lawsuit challenging a government price-setting program.

“Standing is not dispensed in gross; it must be evaluated on a claim-by-claim basis,” attorneys for AstraZeneca PLC said in supplemental filing Monday, pointing to TransUnion LLC v. Ramirez (2021).

“It is telling, then, that despite challenging AstraZeneca’s standing to bring its two APA claims, the Government did not challenge AstraZeneca’s standing to bring its due process claim—just as it did not contest standing for any other manufacturer bringing constitutional claims,” the drugmaker said.

The ...